News



The workshop of this pharmacovigilance program was held in Malang, Thursday, July 14, 2016, in cooperation with Islamic Hospital of Unisma, Malang attended by 30 participants from RSI Unisma Malang and 1 person from NADFC in Surabaya.


The event was officially opened by the Director of the Islamic Hospital of Unisma, Malang, dr. H. Tri Wahyu Sarwiyata, M.Kes.  In his speech, he delivered a glimpse of the activity of Monitoring Drug Side Effects (MESO) at the Islamic Hospital of Unisma, Malang, when pharmacovigilance activity was started in a staggering manner and a lot of confusion, but still we attempted to do what could be achieved first.  In the end, the Islamic Hospital of Unisma, Malang, can submit MESO report regularly since 2015 to NADFC RI.  In addition, he appealed to all participants present to take advantage of the time and knowledge obtained at the workshop and can be practiced in the Hospital.


As a speaker, dr. Jarir At Thobari, PhD from the Faculty of Medicine, University of Gajah Mada, delivered the material on Pharmacovigilance and Patient Safety.  He said that globally, monitoring pharmacovigilance was not only done against the visible side effects of drugs, but also against programmatic errors/medication errors.  In the event of drug side effects, recording and reporting could be made, provided that the report was confidential, so that the healthcare professionals should not hesitate to do the reporting.


In the final part, Ms. Siti Asfijah A, S.Si., Apt., M.MedSc as the Head of Subdirectorate of Surveillance and Risk Analysis of Therapeutic Product and Household Medical Supplies, delivered the material about Pharmacovigilance/MESO Program in Indonesia.  At the end of the session she said that the key to successful implementation of pharmacovigilance is the setting up, in which the support of high level management as a form of commitment that pharmacovigilance is part of the patient safety.  He also gave some suggestions for the Islamic Hospital of Unisma, Malang, among which was to do flagging for patients as a history for patients so as to prevent the occurrence of the same side effects in the patient, for special cases of communication should be done regularly and ad hock, and if possible, can be made in the form of internal bulletin.  The workshop was closed by the Director of the Islamic Hospital of Unisma, Malang, dr. H. Tri Wahyu Sarwiyata, M.Kes. (rsw)


How do you think the content and appearance of this website?




logo dsras Email Rapid Alert System

Selamat email anda telah berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia.

 

logo dsras Email Rapid Alert System

Anda ingin berhenti berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia?